Showing results (91-100 of 134) with videos related to
Sort By:
Pageof 14
Sensors (Basel, Switzerland)|August 12, 2023
Investigating UAV-Based Applications in Indoor-Outdoor Sports Stadiums and Open-Air Gatherings for Different Interference Conditions beyond 5G NetworksAkhil Gupta, Prakhar Saini, Banala Sharath Teja, et al.Gastroenterology|February 5, 2008
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approachJean-Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, et al.Clinical Endocrinology|February 13, 2010
Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapySeán J Costelloe, Nancy Wassef, Josephine Schulz, et al.Journal of Hepatology|April 10, 2014
Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE studyZobair M Younossi, Maria Stepanova, Stefan Zeuzem, et al.Hepatology (Baltimore, Md.)|February 24, 2006
The influence of T cell cross-reactivity on HCV-peptide specific human T cell responsePatrick T F Kennedy, Simonetta Urbani, Rebecca A Moses, et al.The American Journal of Gastroenterology|October 3, 2022
Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in EnglandMaría Fernanda Guerra-Veloz, Khin Han, Kathryn Oakes, et al.Hepatology (Baltimore, Md.)|August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseSudeep Tanwar, Paul M Trembling, Indra N Guha, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2015
Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in GhanaAlexander J Stockdale, Richard Odame Phillips, Apostolos Beloukas, et al.Journal of Hepatology|September 3, 2011
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antiviralsPatrice Cacoub, Marc Bourlière, Jann Lübbe, et al.Antiviral Therapy|October 26, 2011
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trialMichael Manns, Henk Reesink, Thomas Berg, et al.Pageof 14